CLEC11A and metabolic dysfunction-associated steatotic liver disease: The concentrations of stem cell growth factor (SCGFβ) and GROα were significantly increased in patients with NAFLD with cirrhosis compared to patients with NAFLD with simple steatosis and healthy controls.